Status:
COMPLETED
Effect of Supplemental Oxygen on Perioperative BNP Concentration in Cardiac Risk Patients
Lead Sponsor:
Medical University of Vienna
Conditions:
Supplemental Oxygen
Brain Natriuretic Peptide
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The effect of supplemental oxygen on surgical site infections was already investigated in several studies before. Although, oxygen is one of the most used medical therapy in hospitalized patients, the...
Eligibility Criteria
Inclusion
- Patients over 45 years on age, which fulfill 1 or more of the following 4 criteria undergoing non-cardiac surgery:
- History of coronary artery disease
- History of peripheral arterial disease
- History of stroke OR
- Any of 3 of 7 A) Age ≥ 70 years B) Undergoing major surgery C) History of congestive heart failure D) History of transient ischemic attack E) Diabetes and currently taking an oral hypoglycemic agent or insulin F) History of Hypertension
- Further inclusion criteria are:
- Written informed consent
- Elective major abdominal open surgery or laparoscopically assisted procedures scheduled to take over two hours done under general anesthesia (colorectal, urology, gynecology, liver and pancreatic surgery)
Exclusion
- Symptoms of infection or sepsis
- Preoperative inotropic therapy
- Patients under ICU treatment
- Oxygen dependent patients
- History of severe heart failure and/or ejection fraction \< 30%
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2020
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT03366857
Start Date
December 1 2017
End Date
May 30 2020
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090